KIR3DL1 and autoimmune disease: Therefore, we analyzed CD8+ T cells expressing inhibitory KIRs (which we refer to as KIR+CD8+ T cells) (9, 10) in the peripheral blood of patients with autoimmune diseases and age- and gender-matched healthy controls (HCs).